Marty Makary's Resignation Highlights FDA's Leadership Woes
Marty Makary's recent resignation from the FDA underscores persistent leadership challenges and political pressures facing the agency.
FDA
Recent coverage
From the wire
RFK ally confirms she was fired by FDA: ‘I learned so much and leave with no regrets’
Meet the hospital dogs ‘making a real difference’ by getting sick kids to smile
STAT+: FDA drug center head Tracy Beth Høeg leaves as agency faces leadership vacuum
FDA chief Marty Makary resigns from agency, ending tumultuous tenure
FDA approves AstraZeneca’s new kind of hypertension drug
Opinion: Marty Makary misunderstood something fundamental about the FDA
Makary resigns; Biogen reports Alzheimer’s data; and more
CDER chief Høeg expected to leave FDA, according to source
Candel reports prostate cancer drug's long-term data ahead of FDA filing
FDA’s leadership void leaves biotech with renewed ‘uncertainty’
No child deaths definitively linked to Covid shots, FDA says
FDA's unreleased Covid vaccine deaths report is published by lawmaker
Why Real-World Evidence Is Becoming the Missing Link Between Innovation and Patient Care in Oncology
What the FDA won't tell you about your medications (transcript, Propublica)
STAT+: A political contest in the U.K. could shake up drug pricing
With new data, Regenxbio to seek FDA approval of Duchenne gene therapy
Half of AI Health Advice Is Wrong—And Seems Just Right